Literature DB >> 29860541

Endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) in non-communicating hydrocephalus (NCH): comparison of outcome profiles in Nigerian children.

Enoch Ogbonnaya Uche1, Chukwuemeka Okorie2, Izuchukwu Iloabachie2, Dubem S Amuta2, Nkechinyere J Uche3.   

Abstract

BACKGROUND: Endoscopic third ventriculostomy (ETV) and ventriculo-peritoneal shunt (VPS) although recognized surgical options for non-communicating hydrocephalus have debatable applications.
OBJECTIVE: We analysed a prospective cohort of age-matched children with non-tumor, non-communicating hydrocephalus treated with the two surgical modalities using clinically measurable parameters.
METHODS: A single institution analysis of age-matched patients with non-communicating hydrocephalus treated with VPS or ETV over a 3-year period. Occipitofrontal circumference (OFC), milestone, shunt independence as well as complication profiles of patients were recorded and analysed. Mean follow-up period was 1.27 ± 0.19 years 95%CI). Data analysis were performed using SPSS version 15, Chicago, IL. Statistical tests were set at 95% significance level.
RESULTS: Fifty-five patients were enrolled, 25 patients had ETV, while 30 had VPS. Mean age was 2.3 ± 0.7 years (95% CI) with a range of 3 months to 4.5 years. Aqueductal stenosis was the most common indication. OFC profile decline was significant among the VPS group when compared with ETV group at 3 months follow-up (χ2 = 7.59, df = 1, p < 0.05). There was no difference among the two treatment groups χ2 = 2.47, df = 1, p > 0.05) in milestone profile. Thirteen percent of VPS, compared to (4%) ETV patients, had sepsis (χ2 = 4.59, df = 1 p < 0.05). Ninety-two percent of ETV patients remained shunt free, while 80% of shunted patients achieved ETV independence. Two patients died among the VPS group compared to one patient in the ETV group.
CONCLUSION: VPS compared to ETV is associated with an earlier milestone and OFC response. ETV is associated with lower rates of sepsis and mortality.

Entities:  

Keywords:  Endoscopic third ventriculostomy; Milestones; Non-communicating hydrocephalus; Outcome; Ventriculoperitoneal shunt

Mesh:

Year:  2018        PMID: 29860541     DOI: 10.1007/s00381-018-3848-0

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  25 in total

Review 1.  Surgery of hydrocephalus: past, present and future.

Authors:  J F Hirsch
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric patients: a decision analysis.

Authors:  James M Drake; Abhaya V Kulkarni; John Kestle
Journal:  Childs Nerv Syst       Date:  2009-01-13       Impact factor: 1.475

3.  Epidemiology of infantile hydrocephalus in Sweden: a clinical follow-up study in children born at term.

Authors:  E Fernell; B Hagberg; G Hagberg; G Hult; L von Wendt
Journal:  Neuropediatrics       Date:  1988-08       Impact factor: 1.947

4.  Congenital malformations of the central nervous system in Enugu, Nigeria.

Authors:  S C Ohaegbulam; N Saddeqi
Journal:  East Afr Med J       Date:  1979-10

5.  Challenges and outcome of cranial neuroendoscopic surgery in a resource constrained developing African country.

Authors:  E O Uche; E Okorie; J Emejulu; O Ajuzieogu; N J Uche
Journal:  Niger J Clin Pract       Date:  2016 Nov-Dec       Impact factor: 0.968

6.  The efficacy analysis of endoscopic third ventriculostomy in infantile hydrocephalus.

Authors:  Zhenhua He; Caixia An; Xinding Zhang; Xiaodong He; Qiang Li
Journal:  J Korean Neurosurg Soc       Date:  2015-02-26

Review 7.  Endoscopic third ventriculostomy in obstructive infantile hydrocephalus: remarks about the so-called 'unsuccessful cases'.

Authors:  Pasquale Gallo; Alexandru Szathmari; Sara De Biasi; Carmine Mottolese
Journal:  Pediatr Neurosurg       Date:  2011-05-03       Impact factor: 1.162

8.  Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus.

Authors:  Abhaya V Kulkarni; James M Drake; Conor L Mallucci; Spyros Sgouros; Jonathan Roth; Shlomi Constantini
Journal:  J Pediatr       Date:  2009-05-15       Impact factor: 4.406

9.  New and improved ways to treat hydrocephalus: Pursuit of a smart shunt.

Authors:  Barry R Lutz; Pranav Venkataraman; Samuel R Browd
Journal:  Surg Neurol Int       Date:  2013-03-19

Review 10.  Paradigm shift in hydrocephalus research in legacy of Dandy's pioneering work: rationale for third ventriculostomy in communicating hydrocephalus.

Authors:  Dan Greitz
Journal:  Childs Nerv Syst       Date:  2007-03-17       Impact factor: 1.475

View more
  4 in total

Review 1.  Endoscopic third ventriculostomy versus shunt for pediatric hydrocephalus: a systematic literature review and meta-analysis.

Authors:  Pavlos Texakalidis; Muhibullah S Tora; Jeremy S Wetzel; Joshua J Chern
Journal:  Childs Nerv Syst       Date:  2019-05-25       Impact factor: 1.475

2.  Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in pediatric and adult population: a systematic review and meta-analysis.

Authors:  Apurva Pande; Nayan Lamba; Marco Mammi; Paulos Gebrehiwet; Alyssa Trenary; Joanne Doucette; Stefania Papatheodorou; Adomas Bunevicius; Timothy R Smith; Rania A Mekary
Journal:  Neurosurg Rev       Date:  2020-05-31       Impact factor: 3.042

Review 3.  Comparing the Efficiency of Two Treatment Methods of Hydrocephalus: Shunt Implantation and Endoscopic Third Ventriculostomy.

Authors:  Seifollah Gholampour; Mehrnoush Bahmani; Azadeh Shariati
Journal:  Basic Clin Neurosci       Date:  2019-05-01

Review 4.  Efficacy and safety of flexible versus rigid endoscopic third ventriculostomy in pediatric and adult populations: a systematic review and meta-analysis.

Authors:  Alessandro Boaro; Bhargavi Mahadik; Anthony Petrillo; Francesca Siddi; Sharmila Devi; Shreya Chawla; Abdullah M Abunimer; Alberto Feletti; Alessandro Fiorindi; Pierluigi Longatti; Francesco Sala; Timothy R Smith; Rania A Mekary
Journal:  Neurosurg Rev       Date:  2021-06-25       Impact factor: 2.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.